Browsing Tag
SaMD
4 posts
Respiree’s AI-enabled 1Bio software gets HSA greenlight for acute deterioration detection
Respiree’s AI-powered 1Bio AI-Acute gets HSA approval in Singapore for detecting acute deterioration. Find out what’s next in its global expansion push.
Can AI predict heart failure years earlier? Inside Anumana’s breakthrough AHA 2025 results
Anumana’s FDA-cleared ECG-AI platform enhances heart failure prediction and expands into perioperative care with Boston Scientific’s backing. Learn more.
Can Median Technologies’ €23.9m boost reshape AI cancer screening in the U.S. and Europe?
Median Technologies raises €23.9M to fund U.S. eyonis® launch and unlock EIB loan access. Read how the capital boost affects its growth outlook.
Median Technologies secures €37.5m EIB funding to advance eyonis AI cancer diagnostics and US launch
Median Technologies secures €37.5M from the European Investment Bank to accelerate AI-driven eyonis® cancer screening software commercialization in the US and EU.